Showing results (1-10 of 839) with videos related to
Sort By:
Pageof 84
Journal of Critical Care|December 1, 1994
Dextran 70 administration after trauma-hemorrhagic shock does not impair cellular immune functionsJ F Schmand, A Ayala, M H Morrison, et al.Critical Care Medicine|May 1, 1995
Effects of hydroxyethyl starch after trauma-hemorrhagic shock: restoration of macrophage integrity and prevention of increased circulating interleukin-6 levelsJ F Schmand, A Ayala, M H Morrison, et al.The Journal of Surgical Research|September 1, 1995
PAF-antagonist administration after hemorrhage-resuscitation prevents splenocyte immunodepressionR Zellweger, A Ayala, J F Schmand, et al.Critical Care Medicine|July 1, 1994
Effects of trauma, duration of hypotension, and resuscitation regimen on cellular immunity after hemorrhagic shockJ F Schmand, A Ayala, I H ChaudryArchives of Surgery (Chicago, Ill. : 1960)|January 1, 1993
Modulation of macrophage membrane phospholipids by n-3 polyunsaturated fatty acids increases interleukin 1 release and prevents suppression of cellular immunity following hemorrhagic shockW Ertel, M H Morrison, A Ayala, et al.The American Journal of Physiology|July 1, 1995
Hypoxemia in the absence of blood loss or significant hypotension causes inflammatory cytokine releaseW Ertel, M H Morrison, A Ayala, et al.Cytokine|November 1, 1994
Biological significance of elevated TNF levels: in vivo administration of monoclonal antibody against tnf following haemorrhage shock increases the capacity of macrophages to release TNF while restoring immunoresponsivenessW Ertel, M H Morrison, A Ayala, et al.Surgery|August 1, 1991
Insights into the mechanisms of defective antigen presentation after hemorrhageW Ertel, M H Morrison, A Ayala, et al.The Journal of Trauma|May 1, 1991
Eicosanoids regulate tumor necrosis factor synthesis after hemorrhage in vitro and in vivoW Ertel, M H Morrison, A Ayala, et al.Blood|October 1, 1991
Chloroquine attenuates hemorrhagic shock-induced suppression of Kupffer cell antigen presentation and major histocompatibility complex class II antigen expression through blockade of tumor necrosis factor and prostaglandin releaseW Ertel, M H Morrison, A Ayala, et al.Pageof 84